US Stock MarketDetailed Quotes

SWTX SpringWorks Therapeutics

Watchlist
  • 38.040
  • +1.170+3.17%
Close Jul 26 16:00 ET
  • 38.040
  • 0.0000.00%
Post 20:02 ET
2.82BMarket Cap-7386P/E (TTM)

About SpringWorks Therapeutics Company

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.

Company Profile

SymbolSWTX
Company NameSpringWorks Therapeutics
Listing DateSep 13, 2019
Issue Price18.00
Founded2017
CEOMr. Saqib Islam, J.D.
MarketNASDAQ
Employees305
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address100 Washington Boulevard
CityStamford
ProvinceConnecticut
CountryUnited States of America
Zip Code06902
Phone1-203-883-9490
Websitehttp://www.springworkstx.com

Company Executives

  • Name
  • Position
  • Salary
  • Saqib Islam, J.D.
  • Director and Chief Executive Officer
  • 18.35M
  • Tai-An Lin
  • Chief Scientific Officer
  • --
  • Daniel Pichl
  • Chief People Officer
  • --
  • Dr. Badreddin Edris, PhD
  • Chief Operating Officer
  • 6.64M
  • Francis I. Perier, Jr
  • Chief Financial Officer
  • 3.74M
  • Bhavesh Ashar, M.B.A.
  • Chief Commercial Officer
  • --
  • Dr. James Cassidy, M.D.,PhD
  • Chief Medical Officer
  • 4.31M
  • Michael Nofi
  • Chief Accounting Officer
  • --
  • Daniel S. Lynch, M.B.A.
  • Chairman of the Board
  • 545.14K
  • Carlos Alban
  • Independent Director
  • 507.64K
  • Alan Fuhrman
  • Independent Director
  • 520.14K
  • Dr. Freda C. Lewis-Hall,M.D.
  • Independent Director
  • 508.45K
  • Dr. Julie Hambleton, M.D.
  • Independent Director
  • 520.14K
  • Herschel S. Weinstein, J.D.
  • General Counsel and Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg